Skip to content
CONTRACT MANUFACTURING — LINDEN NJ — RENO NV SPEC SHEET / DMG-PROC-14.4

The 14-Day Concept-to-Capsule Workflow

A precise, contractual timing promise from Dr. Magdalena Donat's R&D bench to a retail-shippable batch. Five gated phases, instrument-grade verification, and ISO 22716 / cGMP compliance engineered into every hour — not bolted on at the end.

  • 14days, Brief → Retail-Ready
  • 5gated phases
  • 5,000unit MOQ
  • 84,000sq ft cGMP footprint
05 GATES — DAY 1 TO DAY 14

Five gates from kickoff to first shippable batch.

Each phase has a fixed deliverable, a fixed owner, and a fixed exit criterion. You do not advance to the next phase until the previous gate's spec sheet is signed.

  1. PHASE 01 DAY 1 — DAY 3

    Brief & Formulation Lock

    90-minute consult with the head of R&D, ingredient sourcing through our 12-step library, label-claim review, and a signed formulation specification that freezes the active and excipient bill of materials.

    Owner
    Head of R&D + Client
    Deliverable
    Locked Formulation Spec v1.0
    Exit gate
    Signed spec sheet + raw material POs
  2. PHASE 02 DAY 4 — DAY 7

    Bench Sample & Sensory Panel

    Two 250-capsule bench runs on a manual capsule machine, screened by 11 PhD chemists and 4 registered dietitians. You receive a written sensory report covering dissolution, organoleptics, and label-claim feasibility.

    Owner
    R&D bench + Regulatory
    Deliverable
    500-count bench sample + sensory report
    Exit gate
    Client sample approval + sign-off
  3. PHASE 03 DAY 8 — DAY 10

    Stability & Potency Verification

    Accelerated stability under ICH Q1A conditions, NIR spectroscopic potency verification on every batch, and a regulatory check of all structure/function claims against current FDA guidance. No shortcuts, no surprise rejections.

    Owner
    Analytical Chemist + Regulatory
    Deliverable
    Stability report + NIR potency sheet
    Exit gate
    Label-claim clearance memo
  4. PHASE 04 DAY 11 — DAY 13

    Pilot Run on Production Line

    5,000-unit pilot on an automated encapsulation line with inline NIR verification, full GMP batch records, and a documented change-control log. The pilot run validates your process at production scale before the full run.

    Owner
    Production Manager + QA
    Deliverable
    5,000-unit pilot batch + batch record
    Exit gate
    QA release + client visual approval
  5. PHASE 05 DAY 14

    Retail-Ready Batch

    Full encapsulation run, label compliance review, retail-ready packaging on approved components, and a Certificate of Analysis for every SKU. Your first shippable batch leaves the floor on Day 14.

    Owner
    QA + Logistics
    Deliverable
    Finished units + CofA per SKU
    Exit gate
    Shipment dispatched or 3PL transfer
Donat Mg capsule encapsulation line at the Linden NJ facility with inline NIR spectrometer.
LINDEN NJ — LINE 03 / CAPSULE & NIR VERIFICATION
Gummy depositor line at Donat Mg's Reno NV facility.
RENO NV — GUMMY DEPOSITOR
Inline NIR spectrometer probe verifying capsule potency in real time.
INLINE NIR POTENCY VERIFICATION
EQUIPMENT & FACILITY — 84,000 SQ FT

The floor where the 14 days happen.

Two cGMP-certified facilities — 1420 Pierce Street, Linden NJ and a sister site in Reno NV — running eight encapsulation machines, four gummy depositors, and an inline NIR spectroscopic potency verifier on every production line. No upcharge, no batch reruns, no mystery about what is in the capsule.

  • CAPSULE LINES 8 × automatic, sizes 00 / 0 / 1
  • GUMMY DEPOSITORS 4 × starch-mold + silicone
  • NIR SPECTROMETER Inline, every line, no upcharge
  • HOMOGENIZERS 2 × high-shear, 1,500 L
  • QC LAB HPLC, ICP-MS, dissolution bath
  • ENVIRONMENT ISO 7 cleanroom, 21 CFR Part 111
See Facilities & Team →
COMPLIANCE — ENGINEERED IN, NOT BOLTED ON

How ISO 22716 and cGMP are built into the workflow.

Compliance is not a finish line — it is a designed-in property of every gate. Here is exactly where each certification earns its keep across the 14 days.

01 ISO 22716

Documentation at the Brief

Phase 01 opens with a full production-spec document — premises, equipment, personnel, materials — reviewed against ISO 22716 §6 before raw materials are even ordered. Documentation is the first deliverable, not the last.

PHASE 01 — BRIEF
02 21 CFR Part 111

Master Batch Records at the Bench

Each bench sample carries a cGMP-compliant batch record: weigh tickets, in-process checks, deviation handling, and signature trails. The same template scales from 500 capsules to 250,000 — no reformatting, no rework.

PHASE 02 — BENCH
03 NSF GMP for Sport

Banned-Substance Screening on Stability

For Sport-certified SKUs, every raw material is screened against the NSF/ANSI 173 NSF Certified for Sport list, with chain-of-custody documentation filed before the stability clock starts. No retroactive compliance.

PHASE 03 — STABILITY
04 Organic QAI

Identity-Preserved Runs on the Floor

Organic-certified SKUs run on a dedicated, identity-preserved line with segregated storage and a separate CofA. Audit-ready at every shift change, not just at the annual inspection window.

PHASE 04 — PILOT RUN
HELD CERTIFICATIONS — VERIFIED FY 2024
  • ISO 22716
  • cGMP · 21 CFR Part 111
  • NSF GMP for Sport
  • Organic QAI
FY 2024 — TRAILING 12 MONTHS

The numbers behind the timeline.

2.1M finished units shipped in 2024 across 47 SKUs SOURCE: Internal logistics dashboard, FY 2024
99.4% on-time delivery rate over the trailing 12 months SOURCE: On-time delivery log, TTM to Q2 2025
412 label compliance reviews cleared with zero FDA warning letters since 2019 SOURCE: Regulatory affairs register, 2019–present
28 active NDIN and structure/function claim approvals held with the FDA in 2024 SOURCE: FDA inventory, FY 2024

Most founders walk in expecting an eight-month contract-manufacturing cycle. By the end of the first consult, we have usually collapsed that to 28 days from contract signing — and to a 14-day prototype-to-capsule runway once the spec sheet is signed. The trick is not magic. It is a frozen formulation, instrument-grade verification, and a compliance team that has already cleared 412 label reviews. The chemistry is straightforward when the process is engineered for it.

Dr. Magdalena Donat Founder & Head of R&D — Former Pfizer formulation scientist DMG-RND / 2014–present / 86-person team

Ready to map your 14 days? The consult is 30 minutes, free, with the head of R&D.

Book a Free Formulation Consult